Nonprofit · EIN 23-7121131
LUDWIG INSTITUTE FOR CANCER RESEARCH
Tax-exempt · NEW YORK, NY 10016
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $63,043,209 | $64,271,029 | -$1,227,820 | $15,647,314 | $14,569,359 | $1,077,955 |
| December 31, 2023 | 990 | $72,893,952 | $71,353,269 | $1,540,683 | $19,252,124 | $16,568,652 | $2,683,472 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $61,015,700
- Program service revenue
- $0
- Investment income
- $42,664
- Royalties
- $1,957,672
- Other revenue
- $1,984,845
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $4,272,142
- Other salaries and wages
- $3,940,114
- Salaries, compensation and benefits (total)
- $9,935,499
- Professional fundraising fees
- $0
- Legal fees
- $275,666
- Accounting fees
- $129,518
- Occupancy
- $793,464
- Travel
- $556,560
- Program services (functional)
- $53,851,321
- Management and general (functional)
- $10,419,708
Balance sheet and other
- Total assets, start of year
- $19,252,124
- Total assets, end of year
- $15,647,314
- Total liabilities, end of year
- $14,569,359
- Net assets, end of year
- $1,077,955
- Publicly traded securities
- $33
- Gross receipts
- $63,043,209
- Employees
- 31
- Volunteers
- 0
- Year formed
- 1971
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| Xing Chen | Director (From 7/24) Trustee or director | 1 | $0 | $1,010,543 | $186,454 |
| Dr Chi Van Dang | Dir, Sci. Dir, CEO (From 7/24) Trustee or director, Officer | 50 | $1,106,568 | $0 | $73,583 |
| Dr Jonathan Skipper | President (From 7/24) Officer | 45 | $789,223 | $0 | $73,583 |
| Edward A McDermott Jr | Dir, Board Chair (From 7/24) Trustee or director, Officer | 44 | $14,794 | $604,133 | $51,800 |
| Thomas Baenninger | Chief Financial Officer Officer | 40 | $546,105 | $0 | $116,742 |
| Yang Shi | Group Leader Highest-paid employee | 10 | $467,668 | $0 | $62,934 |
| George Coukos | Branch Director Key employee | 40 | $416,454 | $0 | $85,341 |
| Patrice Morin | Deputy Scient. Dir. Officer | 45 | $406,205 | $0 | $75,269 |
| Xin Lu | Branch Director Key employee | 10 | $408,289 | $0 | $54,740 |
| Michael Macaranas | BRANCH ADMINISTRATOR(END 4/24) Highest-paid employee | 40 | $387,157 | $0 | $23,091 |
| Alexander Borissov | SEC. TO BOARD, INTERNAL AUDIT Highest-paid employee | 37 | $287,353 | $0 | $76,191 |
| Richard White | Group Leader Highest-paid employee | 10 | $272,355 | $0 | $78,038 |
| Gerd Ritter | TECHNOLOGY DEVELOPMENT MANAGER Highest-paid employee | 40 | $267,969 | $0 | $65,638 |
| John L Notter | Dir, Board Chair (End 6/24) Trustee or director | 8 | $15,357 | $99,960 | $0 |
| John D Gordan III | Director Trustee or director | 2 | $11,271 | $84,960 | $0 |
5 more people on this return
| Name | Title | Hours / week | Compensation | From related orgs |
|---|---|---|---|---|
| Jedd Wolchok | DIRECTOR Trustee or director | 2 | $11,271 | $84,960 |
| Dr Nancy Ellen Davidson | Director Trustee or director | 2 | $11,271 | $30,000 |
| Judge Barbara S Jones | Director Trustee or director | 2 | $11,271 | $30,000 |
| Alexandra Johnson | Director Trustee or director | 2 | $11,271 | $30,000 |
| Nicolas Killen | Director Trustee or director | 2 | $11,271 | $30,000 |
990 for the year ended December 31, 2023: 19 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| Dr Chi Van Dang | Director, Scientific Director Trustee or director, Officer | 50 | $1,051,303 | $0 | $75,277 |
| Edward A McDermott Jr | Director, President Trustee or director, Officer | 44 | $0 | $951,807 | $93,653 |
| Dr Jonathan Skipper | Exec Vice-Pres Tech Develop. Officer | 45 | $791,046 | $0 | $75,277 |
| Thomas Baenninger | Chief Financial Officer Officer | 40 | $512,250 | $0 | $112,712 |
| Richard White | Group Leader Highest-paid employee | 10 | $472,041 | $0 | $105,307 |
| Yang Shi | Group Leader Highest-paid employee | 10 | $438,227 | $0 | $59,255 |
| George Coukos | Branch Director Key employee | 40 | $403,977 | $0 | $86,003 |
| Dr Bing Ren | Group Leader Highest-paid employee | 45 | $401,272 | $0 | $68,994 |
| Dr Richard Kolodner | Group Leader Highest-paid employee | 50 | $416,477 | $0 | $51,279 |
| Xin Lu | Branch Director Key employee | 10 | $382,032 | $0 | $51,267 |
| Andrew Shiau | Group Leader Highest-paid employee | 50 | $361,737 | $0 | $61,491 |
| Patrice Morin | Deputy Scient. Dir. Officer | 45 | $313,974 | $0 | $73,833 |
| John L Notter | Director, Board Chairperson Trustee or director | 8 | $28,701 | $127,788 | $0 |
| John D Gordan III | Director Trustee or director | 2 | $10,934 | $82,788 | $0 |
| Jedd Wolchok | DIRECTOR Trustee or director | 2 | $10,934 | $82,788 | $0 |
| Dr Nancy Ellen Davidson | Director Trustee or director | 2 | $10,934 | $30,000 | $0 |
| Judge Barbara S Jones | Director Trustee or director | 2 | $10,934 | $30,000 | $0 |
| Alexandra Johnson | Director Trustee or director | 2 | $10,934 | $30,000 | $0 |
| Nicolas Killen | Director Trustee or director | 2 | $10,934 | $30,000 | $0 |
Address and contacts
- Address (IRS master file)
- 600 3RD AVE FL 32, NEW YORK, NY 10016-1932
- In care of
- % URS KUNZ
- Principal officer (990 for 2024)
- Jonathan Skipper, 600 Third Avenue 32nd Floor, New York, NY 10016
- Signed the 990
- Jonathan Skipper, President
- Phone
- (212) 450-1500
- Website
- www.ludwigcancerresearch.org
- Return prepared by
- PWC US TAX LLP
Mission
THE LUDWIG INSTITUTE FOR CANCER RESEARCH LTD IS AN INTERNATIONAL NOT-FOR-PROFIT ORGANIZATION COMMITTED TO PREVENTING AND CONTROLLING CANCER THROUGH INTEGRATED LABORATORY AND CLINICAL RESEARCH.
Program accomplishments
- LINE 4A - LABORATORY AND CLINICAL RESEARCH LEADING TO CLINICAL APPLICATIONS THE LUDWIG INSTITUTE FOR CANCER RESEARCH LTD WAS FOUNDED IN 1971 AS AN INTERNATIONAL NOT-FOR-PROFIT RESEARCH INSTITUTE DEDICATED TO IMPROVING THE UNDERSTANDING, PREVENTION, DETECTION AND TREATMENT OF CANCER. THE LUDWIG INSTITUTE TAKES RESPONSIBILITY FOR THE DISCOVERY CONTINUUM FROM CONDUCT OF INNOVATIVE LABORATORY AND CLINICAL RESEARCH AND EXTENDING TO EXPLORING THE CLINICAL POTENTIAL OF NEW DISCOVERIES IN CLINICAL STUDIES, TO FACILITATE THE TRANSLATION OF PROMISING DISCOVERIES RELATED TO CANCER INTO APPLICATIONS FOR HUMAN BENEFIT. MAKING MEANINGFUL ADVANCES THAT WILL ULTIMATELY TRANSFORM CARE FOR CANCER PATIENTS IS CENTRAL TO THE LUDWIG INSTITUTE'S MISSION. THE LUDWIG INSTITUTE ENGAGES LEADING CANCER SCIENTISTS AND CLINICIANS IN AN INTEGRATED LABORATORY AND CLINICAL RESEARCH EFFORT TO CONFRONT THE GLOBAL CHALLENGE OF CANCER. ALL LABORATORY AND CLINICAL RESEARCH FINANCED BY THE LUDWIG INSTITUTE IS CARRIED OUT BY ITS IN-HOUSE RESEARCH STAFF OR THROUGH RESEARCH COLLABORATIONS INVOLVING INSTITUTE STAFF AND EXTERNAL INVESTIGATORS. CLINICAL STUDIES ARE IMPLEMENTED THROUGH LOCALLY SPONSORED, INVESTIGATOR-INITIATED CLINICAL TRIALS MANAGED THROUGH ITS BRANCH'S HOSPITAL AFFILIATIONS OR THROUGH NON-PROFIT CLINICAL TRIAL NETWORKS. THE LUDWIG INSTITUTE HAS A STAFF OF AROUND 485 FULL TIME EQUIVALENTS SCIENTISTS, CLINICIANS AND SUPPORT PERSONNEL AS OF DECEMBER 31, 2024, LOCATED IN FOUR COUNTRIES AND FOCUSED ON MULTIPLE ASPECTS OF CANCER RESEARCH. MORE THAN 99% OF THE TOTAL COST OF THE LUDWIG INSTITUTE IS FUNDED BY OWN RESOURCES. IN ADDITION TO SELF-GENERATED INCOME FROM INTELLECTUAL PROPERTY, A SIGNIFICANT AMOUNT IS RECEIVED FROM THE LICR FUND, INC., A DELAWARE SUPPORTING ORGANIZATION DEDICATED TO MAINTAINING AN INVESTMENT PORTFOLIO FOR THIS PURPOSE. THIS FUNDING SETUP GIVES LUDWIG INSTITUTE INVESTIGATORS THE FREEDOM TO TACKLE INNOVATIVE LONG-TERM RESEARCH AND ENCOURAGES AND ENABLES MULTIDISCIPLINARY TEAMS OF INVESTIGATORS TO ADDRESS SIGNIFICANT AND RELATIVELY COMPLEX CHALLENGES POSED BY CANCER. THE RESEARCH ACTIVITIES OF THE LUDWIG INSTITUTE, TOGETHER WITH THOSE OF THE LUDWIG CENTERS ESTABLISHED AT SIX U.S. ACADEMIC INSTITUTIONS WITH FUNDING FROM A TRUST UNDER THE WILL OF DANIEL K. LUDWIG ARE DESIGNATED COLLECTIVELY AS "LUDWIG CANCER RESEARCH," AN INTERNATIONAL COMMUNITY OF DISTINGUISHED SCIENTISTS DEDICATED TO STUDYING CANCER AND ADVANCING ITS PREVENTION, DIAGNOSIS AND TREATMENT. THE DEVELOPMENT, PROTECTION AND LICENSING OF INTELLECTUAL PROPERTY GENERATED BY RESEARCH AND TECHNOLOGY DEVELOPMENT IS FUNDAMENTAL TO THE LUDWIG INSTITUTE'S COMMITMENT TO TRANSLATE ITS DISCOVERIES FOR PATIENT BENEFIT. INCOME FROM THESE ACTIVITIES FINANCED RESEARCH EXPENDITURES AMOUNTING TO USD 2.0 MILLION IN 2024. THE LUDWIG INSTITUTE ALSO MANAGES ITS IP AND PATENTS FOR PUBLIC BENEFIT. THIS MEANS THAT THE IP IS MADE FREELY AVAILABLE TO THE ACADEMIC RESEARCH COMMUNITY. IN 2024, LUDWIG INSTITUTE INVESTIGATORS PUBLISHED 227 PRIMARY RESEARCH ARTICLES AND 52 REVIEWS, BOOK CHAPTERS AND COMMENTARIES. PROGRESS WAS MADE IN THE STUDY OF TUMOR BIOLOGY, CANCER GENOMICS, CANCER PREVENTION, THE TUMOR MICRO-ENVIRONMENT AND TUMOR IMMUNOLOGY. IN 2024, TEN NEW U.S. PATENTS AND THREE NEW EUROPEAN PATENTS WERE ISSUED. NINE NEW U.S. APPLICATIONS AND A FURTHER SIX NEW INTERNATIONAL PATENT APPLICATIONS WERE ALSO FILED.Expenses $53,851,321
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 23-7121131
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1971
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Assets (IRS master file)
- $15,647,314
- Income (IRS master file)
- $63,043,209
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $63,043,209 | $64,271,029 | $15,647,314 | XML |
| 990 | December 2023 | $72,893,952 | $71,353,269 | $19,252,124 | XML |
| 990 | December 2022 | $102,443,688 | $107,869,697 | $21,583,740 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 23-7121131).
Questions about LUDWIG INSTITUTE FOR CANCER RESEARCH
- What is the EIN of LUDWIG INSTITUTE FOR CANCER RESEARCH?
- The employer identification number (EIN) of LUDWIG INSTITUTE FOR CANCER RESEARCH is 23-7121131.
- Is LUDWIG INSTITUTE FOR CANCER RESEARCH tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1971.
- Are donations to LUDWIG INSTITUTE FOR CANCER RESEARCH tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does LUDWIG INSTITUTE FOR CANCER RESEARCH file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of LUDWIG INSTITUTE FOR CANCER RESEARCH due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did LUDWIG INSTITUTE FOR CANCER RESEARCH last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of LUDWIG INSTITUTE FOR CANCER RESEARCH?
- The 990 for the year ended December 31, 2024 names Jonathan Skipper.
- Who are the officers and directors of LUDWIG INSTITUTE FOR CANCER RESEARCH?
- The 990 for the year ended December 31, 2024 lists 20 people; 19 received compensation from the organization.
- How much revenue does LUDWIG INSTITUTE FOR CANCER RESEARCH have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $63,043,209, expenses of $64,271,029 and total assets of $15,647,314 at year end.
Other nonprofits in NEW YORK
- NEW YORK UNIVERSITY EIN 13-5562308 · last filed 990 for 2025
- HEALTHFIRST PHSP INC EIN 13-3783732 · last filed 990 for 2024
- THE NEW YORK AND PRESBYTERIAN HOSPITAL EIN 13-3957095 · last filed 990 for 2024
- NYU LANGONE HOSPITALS EIN 13-3971298 · last filed 990 for 2025
- MEMORIAL SLOAN-KETTERING CANCER CENTER EIN 91-2154267 · last filed 990 for 2024
- TRUSTEES OF COLUMBIA UNIVERSITY EIN 13-5598093 · last filed 990 for 2025
- HEALTHFIRST HEALTH PLAN INC EIN 11-3029569 · last filed 990 for 2024
- GS DONOR ADVISED PHILANTHROPY FUND FOR WEALTH MANAGEMENT INC EIN 31-1774905 · last filed 990 for 2024